Iacovos Ghalanos – Life Sciences Head, KPMG Cyprus
24.09.2018
Related Interviews
Nicos Anastasiades – President, Republic of Cyprus
In an exclusive interview, President Nicos Anastasiades outlines his public health priorities, the continuing importance of the pharmaceutical industry to Cyprus’s economy, and the nation’s attractiveness as an international investment…
George Campanellas – Director General, Invest Cyprus (Cyprus Investment…
George Campanellas provides an overview of Invest Cyprus’ strategy for attracting foreign investment into Cyprus. He touches on sourcing interest from a wide range of sectors and highlights what makes…
Varnavas Varnava – Founder and Director, Biotronics, Cyprus
Varnavas Varnava, the founder and director of Biotronics, highlights the importance of diversification when operating in a small market, as well as discloses his future plans for the company and…
New Special Report on Pharma in Cyprus
With a population of just 1.2 million and a proportionately small pharmaceutical market by EU standards, Cyprus is often overlooked as a healthcare and life sciences investment destination. However, with…
Cyprus: Sun, Sea and…Surgery?
Cyprus is capitalizing on its well-established tourism infrastructure to stake a claim for itself as one of Europe’s premier medical tourism destinations. “I believe Cyprus can become a really important…
Cyprus Joins the Cannabis Craze
In a move to capitalize on a global market projected to exceed USD 60 billion by 2024, Cyprus has joined a growing number of European nations in legally permitting the…
Latest Report
